Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 5/20 | 0.43 |
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14163150 | 0.87 | RAPGEF4 (0.41) | RAPGEF4ARMEN1KMT2AALDH1A1 | |
| SCHEMBL13386073 | 0.87 | AR (0.35) | RAPGEF4ARMEN1KMT2AALDH1A1 | |
| SCHEMBL9713549 | 0.81 | SELL (0.48) | RAPGEF4MEN1KMT2AALDH1A1KDM4E | |
| Dimesityl Disulfide SCHEMBL896126 | 0.80 | RAPGEF4 (0.43) | RAPGEF4ARMEN1KMT2AALDH1A1 | |
| SCHEMBL11745730 | 0.79 | ALDH1A1 (0.42) | RAPGEF4ARMEN1KMT2AALDH1A1 | |
| SCHEMBL14252164 | 0.79 | MEN1 (0.33) | RAPGEF4ARMEN1KMT2A | |
| SCHEMBL19500052 | 0.79 | AR (0.34) | RAPGEF4ARMEN1KMT2AALDH1A1 | |
| SCHEMBL13386343 | 0.79 | AR (0.49) | RAPGEF4ARMEN1KMT2AALDH1A1 | |
| SCHEMBL758797 | 0.78 | RAPGEF4 (0.41) | RAPGEF4ARMEN1KMT2AALDH1A1 | |
| SCHEMBL5887430 | 0.77 | AR (0.44) | ARMEN1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117466730-A | Preparation method of phenoxy carboxylate herbicide | 山东润博生物科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| WO-2019179288-A2 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | 山东润博生物科技有限公司 | 2019-09-26 | — | — | WO | claimed |
| CN-108947811-A | Preparation method of phenoxy carboxylate herbicide | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108947805-A | A kind of preparation method of phenoxy carboxylic acid choline salt | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108947804-A | A kind of preparation method of chlorobenzene oxycarboxylic acid substance | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108947838-A | A kind of preparation method of 2,4 dichlorophenoxyacetic acid and its salt | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108947837-A | A kind of preparation method of 2,4 dichlorophenoxyacetic acid ester | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108947799-A | A kind of preparation method of chlorobenzene oxycarboxylic acid | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| US-20260001875-A1 | AMINOPYRIMIDINYL DERIVATIVES FOR THE TREATMENT OF PARKINSON'S DISEASE | UNIV DUNDEE (GB) | 2026-01-01 | — | — | US | disclosed |
| EP-4522603-A1 | AMINOPYRIMIDINYL DERIVATIVES FOR THE TREAMENT OF PARKINSON'S DISEASE | University Of Dundee (GB) | 2025-03-19 | — | — | EP | disclosed |
| CN-117736082-A | Preparation method of phenoxy carboxylic acid herbicide | 山东润博生物科技有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117466730-A | Preparation method of phenoxy carboxylate herbicide | 山东润博生物科技有限公司 | 2024-01-30 | — | — | CN | disclosed |
| EP-4276097-A1 | AMINOPYRIMIDINYL DERIVATIVES FOR THE TREAMENT OF PARKINSON'S DISEASE | University Of Dundee (GB) | 2023-11-15 | — | — | EP | disclosed |
| WO-2019179267-A1 | PREPARATION METHOD OF PHENOXYCARBOXYLIC ACID HERBICIDES | 山东润博生物科技有限公司 | 2019-09-26 | — | — | WO | disclosed |
| US-20080139768-A1 | Copolymer Having Cyclic Ether Structure in Main Chain, Optical Member Comprising the Copolymer, and Method of Producing the Same | FUJIFILM CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| US-20080139768-A1 | Copolymer Having Cyclic Ether Structure in Main Chain, Optical Member Comprising the Copolymer, and Method of Producing the Same | FUJIFILM CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| US-20080124508-A1 | Method For Producing Refractive Index Profile Plastic Optical Device | FUJIFILM CORPORATION (JP) | 2008-05-29 | — | — | US | disclosed |
| US-20080124508-A1 | Method For Producing Refractive Index Profile Plastic Optical Device | FUJIFILM CORPORATION (JP) | 2008-05-29 | — | — | US | disclosed |
| US-7343073-B2 | Optical members and compositions for producing them | FUJIFILM CORPORATION (JP) | 2008-03-11 | — | — | US | disclosed |
| US-7343073-B2 | Optical members and compositions for producing them | FUJIFILM CORPORATION (JP) | 2008-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001875-A1 | AMINOPYRIMIDINYL DERIVATIVES FOR THE TREATMENT OF PARKINSON'S DISEASE | LRRK2, XIAP, PARK7 | RAPGEF4 1338/4885AR 2729/4885MEN1 3794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.